Brind.

Zealand Pharma A/S appointed Danske Bank as lead manager for its share buy-back program in the Danish market.

6 reports, 2 independent Updated Mon 00:00
No new developments lately
Reports
6
Developments
3
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Zealand Pharma A/S appointed Danske Bank as lead manager for its share buy-back program in the Danish market.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Danske Bank to manage buy-back for Zealand Pharma in Denmark.1 source
  2. Danske Bank appointed as lead manager for Zealand Pharma A/S share buy-back program.1 source
  3. Zealand Pharma A/S hired Danske Bank to manage its share buy-back program.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped